|
1
|
Kaneko N, Kawano S, Matsubara R, Goto Y,
Jinno T, Maruse Y, Sakamoto T, Hashiguchi Y, Iida M and Nakamura S:
Tongue squamous cell carcinoma producing both parathyroid
hormone-related protein and granulocyte colony-stimulating factor:
A case report and literature review. World J Surg Oncol.
14(161)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Asano S, Urabe A, Okabe T, Sato N and
Kondo Y: Demonstration of granulopoietic factor(s) in the plasma of
nude mice transplanted with a human lung cancer and in the tumor
tissue. Blood. 49:845–852. 1977.PubMed/NCBI
|
|
3
|
Yakisan E, Schirg E, Zeidler C, Bishop NJ,
Reiter A, Hirt A, Riehm H and Welte K: High incidence of
significant bone loss in patients with severe congenital
neutropenia (Kostmann's syndrome). J Pediatr. 131:592–597.
1997.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Takamatsu Y, Simmons PJ, Moore RJ, Morris
HA, To LB and Lévesque JP: Osteoclast-mediated bone resorption is
stimulated during short-term administration of granulocyte
colony-stimulating factor but is not responsible for hematopoietic
progenitor cell mobilization. Blood. 92:3465–3473. 1998.PubMed/NCBI
|
|
5
|
Sidan L, Tianshou L, Yongbing C, Yinchao
N, Changhong L, Lanting L, Qiaochuan L and Lugui Q: Granulocyte
colony-stimulating factor induces osteoblast inhibition by B
lymphocytes and osteoclast activation by T lymphocytes during
hematopoietic stem/progenitor cell mobilization. Biol Blood Marrow
Transplant. 21:1384–1391. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Turhan AB, Binay C, Bor O and Simsek E:
The effects of short-term use of granulocyte colony-stimulating
factor on bone metabolism in child cancer patients. Norh Clin
Istanb. 5:277–281. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Goshen E, Tima Davidson T, Yeshurun M and
Zwas ST: Combined increased and decreased skeletal uptake of F-18
FDG. Clin Nucl Med. 31:520–522. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Christopher MJ and Link DC: Granulocyte
colony-stimulating factor induces osteoblast apoptosis and inhibits
osteoblast differentiation. J Bone Miner Res. 23:1765–1774.
2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kusumahstuti KP, Watabe T, Kitamura N and
Yamamoto T: Diffuse bone marrow uptake related to granulocyte
colony-stimulating factor-producing maxillary sinus carcinoma on
4-borono-2-18F-fluoro-L-phenylalanine positron emission
tomography/computed tomography. World J Nucl Med. 20:188–191.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Morooka M, Kubota K, Murata Y, Shibuya H,
Ito K, Mochizuki M, Akashi T, Chiba T, Nomura T, Ito H and Morita
T: (18)F-FDG-PET/CT findings of granulocyte colony stimulating
factor (G-CSF)-producing lung tumors. Ann Nucl Med. 22:635–639.
2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kuroshima T, Wada M, Sato T, Takano M and
Makino S: G-CSF producing oral carcinoma with diffuse uptake of FDG
in the bone marrow: A case report. Oncol Lett. 15:1241–1245.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pfister DG, Spencer S, Adelstein D, Adkins
D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ,
et al: Head and Neck Cancers, Version 2.2020, NCCN Clinical
Practice Guidelines in Oncology. J Natl Compr Canc Netw.
18:873–898. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Picardi M, Rosa GD, Selleri C, Scarpato N,
Soscia E, Martinelli V, Ciancia R and Rotoli B: Spleen enlargement
following recombinant human granulocyte colony-stimulating factor
administration for peripheral blood stem cell mobilization.
Haematologica. 88:794–800. 2003.PubMed/NCBI
|
|
14
|
Al-Khinji A and Linenberger M: Splenic
infarction and G-CSF. Transfusion. 55(708)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Aubrey-Bassler FK and Sowers N: 613 cases
of splenic rupture without risk factors or previously diagnosed
disease: A systematic review. BMC Emerg Med. 12(11)2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Alshamrani MA, Al-Foheidi M and Abdulrahim
AH: Granulocyte colony stimulating factor (G-CSF) induced splenic
infarction in breast cancer patient treated with dose-dense
chemotherapy regimen. Case Rep Oncol Med. 8174986:2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Stroncek D, Shawker T, Follmann D and
Leitman SF: G-CSF-induced spleen size changes in peripheral blood
progenitor cell donors. Transfusion. 43:609–613. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Pitini V, Ciccolo A, Arrigo C, Aloi G,
Micali C and Torre FL: Spontaneous rupture of spleen during
periferal blood stem cell mobilization in a patient with breast
cancer. Haematologica. 85:559–560. 2000.PubMed/NCBI
|
|
19
|
Masood N, Shaikh AJ, Memon WA and Idress
R: Splenic rupture, secondary to G-CSF use for chemotherapy induced
neutropenia: A case report and review of literature. Cases J.
24(418)2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
de Wolff JF, Planken EV and den Ottolander
GJ: Extreme leucocytosis and splenomegaly in metastasized melanoma.
Neth J Med. 62:164–167. 2004.PubMed/NCBI
|
|
21
|
Tsuruta N, Yatsunami J, Takayama K,
Nakanishi Y, Ichinose Y and Hara N: Granulocyte-macrophage-colony
stimulating factor stimulates tumor invasiveness in squamous cell
lung carcinoma. Cancer. 82:2173–2183. 1998.PubMed/NCBI
|
|
22
|
Tomita T, Fujii M, Tokumaru Y, Imanishi Y,
Kanke M, Yamashita T, Ishiguro R, Kanzaki J, Kameyama K and Otani
Y: Granulocyte-macrophage colony-stimulating factor upregulates
matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP
(MT1-MMP) in human head and neck cancer cells. Cancer Lett.
156:83–91. 2000.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sugimoto C, Fujieda S, Sunaga H, Noda I,
Tanaka N, Kimura Y, Saito H and Matsukawa S: Granulocyte
colony-stimulating factor (G-CSF)-mediated signaling regulates type
IV collagenase activity in human head and neck cancer cells. Int J
Cancer. 93:42–46. 2001.PubMed/NCBI View
Article : Google Scholar
|
